DHR DANAHER CORP

2026Q2 · CUSIP 235851102 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it

2,065

Institutions that reported holding it to the SEC

Net decrease in holders

113

Last quarter 2,178 → now 2,065

How unusual is that

Bottom 20%

Stronger than only 0.6% of US stocks

What the filings say, in one paragraph

2,065 funds held DHR at the end of 2026Q2, down 113 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $25.1B(YoY +4.6%), the P/E is 37.2x, return on equity is 7.6%. DHR has had 32 buying rushes in its history, and the price moved +9.5% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

What happened after each past buying rush 32 times in its history

Quarter of the rush	How unusual then	Price, next 3 months	Price, next 6 months
2025Q4	Top 5%	-18.8%	—
2024Q4	Top 20%	-4.8%	+1.6%
2024Q3	Top 1% in the market	-8.5%	-18.3%
2024Q1	Top 5%	+2.2%	-13.1%
2023Q4	Top 20%	+6.4%	+8.7%
2023Q3	Top 10%	+18.6%	+28.0%
2022Q4	Top 5%	-11.4%	-1.5%
2022Q3	Top 20%	-3.6%	-14.0%
2021Q4	Top 5%	-8.9%	+10.1%
2021Q3	Top 1% in the market	-13.0%	-19.4%
2021Q2	Top 5%	-2.9%	-14.9%
2020Q4	Top 5%	+5.1%	+32.9%
2020Q3	Top 5%	+0.4%	+12.6%
2020Q2	Top 5%	+14.3%	+16.9%
2019Q4	Top 5%	-1.1%	+23.7%
2019Q3	Top 5%	+14.4%	+13.7%
2019Q2	Top 5%	-2.9%	+17.1%
2019Q1	Top 1% in the market	+7.2%	+4.1%
2018Q4	Top 10%	+18.0%	+26.5%
2018Q3	Top 20%	+9.1%	+28.0%
2018Q2	Top 5%	+0.4%	+11.1%
2017Q4	Top 5%	+4.0%	+3.6%
2017Q1	Top 10%	-0.3%	+14.2%
2016Q4	Top 5%	-2.8%	-3.6%
2016Q2	Top 5%	-1.6%	+4.3%
2015Q4	Top 5%	+13.6%	+92.4%
2015Q3	Top 5%	-9.4%	+2.1%
2015Q1	Top 5%	+5.2%	+7.5%
2014Q4	Top 5%	-0.1%	+4.2%
2014Q2	Top 20%	+7.9%	+14.9%
2013Q4	Top 5%	-1.3%	-1.4%
2013Q3	Top 5%	+2.1%	+2.5%

Show all 32 events

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾

Of them, large funds

390

Change in large funds

+33

Total value they hold

$114.0B

Funds buying for the first time

153

Funds that sold out entirely

266

Price change that quarter

+28.4%

Funds holding puts (bearish)

Funds holding calls (bullish)

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)

37.2

EPS (TTM)

$5.64

EPS YoY

+19.8%

Revenue (TTM)

$25.1B

Revenue YoY

+4.6%

Net margin

16.0%

ROE

7.6%

Debt ratio

43.1%

FCF (TTM)

$5.5B

Dividend (TTM)

No dividend

Quarterly Revenue & EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow

Latest quarter $1.1B (2026-03-27)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-26 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.